Literature DB >> 2361735

Prevalence of tri- and tetraantennary glycans of human alpha 1-acid glycoprotein in release of macrophage inhibitor of interleukin-1 activity.

P N Bories1, J Feger, N Benbernou, J D Rouzeau, J Agneray, G Durand.   

Abstract

Based on the affinity for concanavalin A (Con A), human alpha 1-acid glycoprotein (AGP) can be separated by chromatography on Con A-Sepharose gel into three variants: Con A unreactive AGP, Con A weakly reactive AGP, and Con A strongly reactive AGP. When exposed to native AGP or to its glycan variants, murine peritoneal macrophages released a factor that inhibited the interleukin-1 (IL-1) proliferative activity as measured in terms of the thymocyte comitogenic assay. Con A unreactive AGP, which contains tri- and tetraantennary glycans and no biantennae, proved to be more effective than Con A weakly and Con A strongly reactive variants, which contain one and two diantennary glycans, respectively. The inhibitory effect was not a function of the negative charge related to the sialyl residues and was not mediated by the mannosyl-fucosyl receptor.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2361735     DOI: 10.1007/bf00915815

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  17 in total

1.  Interactions of alpha1-acid glycoprotein with the immune system. I. Purification and effects upon lymphocyte responsiveness.

Authors:  K M Chiu; R F Mortensen; A P Osmand; H Gewurz
Journal:  Immunology       Date:  1977-06       Impact factor: 7.397

2.  Changes in serum level and affinity for concanavalin A of human alpha 1-proteinase inhibitor in severe burn patients: relationship to natural killer cell activity.

Authors:  P J Lejeune; B Mallet; C Farnarier; S Kaplanski
Journal:  Biochim Biophys Acta       Date:  1989-02-24

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  Human alpha 1-acid glycoprotein-exposed macrophages release interleukin 1 inhibitory activity.

Authors:  P N Bories; M Guenounou; J Féger; E Kodari; J Agneray; G Durand
Journal:  Biochem Biophys Res Commun       Date:  1987-09-15       Impact factor: 3.575

5.  The use of concanavalin A crossed immuno-affinoelectrophoresis to detect hormone-associated variations in alpha 1-acid glycoprotein.

Authors:  C Wells; T C Bøg-Hansen; E H Cooper; M R Glass
Journal:  Clin Chim Acta       Date:  1981-01-08       Impact factor: 3.786

6.  Evidence for uniformity of the carbohydrate chains in individual glycoprotein molecular variants.

Authors:  B Bayard; J P Kerckaert
Journal:  Biochem Biophys Res Commun       Date:  1980-07-31       Impact factor: 3.575

7.  Interaction of an acute phase reactant, alpha 1-acid glycoprotein (orosomucoid), with the lymphoid cell surface: a model for non-specific immune suppression.

Authors:  D A Cheresh; D H Haynes; J A Distasio
Journal:  Immunology       Date:  1984-03       Impact factor: 7.397

8.  Alterations in relative proportions of microheterogenous forms of human alpha 1-acid glycoprotein in liver disease.

Authors:  N Serbource-Goguel Seta; G Durand; M Corbic; J Agneray; J Fegar
Journal:  J Hepatol       Date:  1986       Impact factor: 25.083

9.  Evidence for alpha-1-acid glycoprotein populations of different pI values after concanavalin A affinity chromatography. Study of their evolution during inflammation in man.

Authors:  I Nicollet; J P Lebreton; M Fontaine; M Hiron
Journal:  Biochim Biophys Acta       Date:  1981-04-28

10.  Potentiation of the T-lymphocyte response to mitogens. I. The responding cell.

Authors:  I Gery; R K Gershon; B H Waksman
Journal:  J Exp Med       Date:  1972-07-01       Impact factor: 14.307

View more
  16 in total

1.  Sialic acid residues play a pivotal role in alpha(1)-acid glycoprotein (AGP)-induced generation of reactive oxygen species in chemotactic peptide pre-activated neutrophil granulocytes.

Authors:  Peter Gunnarsson; Louise Fornander; Peter Påhlsson; Magnus Grenegård
Journal:  Inflamm Res       Date:  2009-08-11       Impact factor: 4.575

2.  Studies on the interaction between hyaluronan and a rat colon cancer cell line.

Authors:  C Samuelsson; S Gustafson
Journal:  Glycoconj J       Date:  1998-02       Impact factor: 2.916

3.  Effect of alpha 1-acidic glycoprotein in the ascitic fluid of cancer patients on human NK cells: selective suppression of interferon-induced NK activation.

Authors:  H Aso; K Tamura; M T Rose; Y Tomioka; M Mizugaki; N Ishida
Journal:  Inflammation       Date:  1999-04       Impact factor: 4.092

Review 4.  Alpha 1-acid glycoprotein (orosomucoid): pathophysiological changes in glycosylation in relation to its function.

Authors:  W van Dijk; E C Havenaar; E C Brinkman-van der Linden
Journal:  Glycoconj J       Date:  1995-06       Impact factor: 2.916

5.  Do synovial fluid acute phase proteins from patients with rheumatoid arthritis originate from serum?

Authors:  E C Havenaar; R J Dolhain; G A Turner; M T Goodarzi; E C van Ommen; F C Breedveld; W van Dijk
Journal:  Glycoconj J       Date:  1997-06       Impact factor: 2.916

6.  Glycosylation of alpha 1-acid glycoprotein in septic shock: changes in degree of branching and in expression of sialyl Lewis(x) groups.

Authors:  E C Brinkman-van der Linden; E C van Ommen; W van Dijk
Journal:  Glycoconj J       Date:  1996-02       Impact factor: 2.916

7.  alpha 1-Acid glycoprotein binds human immunodeficiency virus type 1 (HIV-1) envelope glycoprotein via N-linked glycans.

Authors:  L Rabehi; F Ferriere; L Saffar; L Gattegno
Journal:  Glycoconj J       Date:  1995-02       Impact factor: 2.916

8.  Immunomodulating activities of a natural alpha1-acid glycoprotein and its carbohydrate chains attached to the protein-free polymer.

Authors:  A L Pukhalsky; S D Shyian; E A Kalashnikova; G V Shmarina; D A Pukhalskaya; N V Bovin
Journal:  Mediators Inflamm       Date:  1998       Impact factor: 4.711

9.  Protection by alpha 1-acid glycoprotein against tumor necrosis factor-induced lethality.

Authors:  C Libert; P Brouckaert; W Fiers
Journal:  J Exp Med       Date:  1994-10-01       Impact factor: 14.307

10.  Antiinflammatory properties of hepatic acute phase proteins: preferential induction of interleukin 1 (IL-1) receptor antagonist over IL-1 beta synthesis by human peripheral blood mononuclear cells.

Authors:  H Tilg; E Vannier; G Vachino; C A Dinarello; J W Mier
Journal:  J Exp Med       Date:  1993-11-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.